Thematics Asset Management Increases Stock Position in Danaher Corporation $DHR

Key Points

• Thematics Asset Management increased its holdings in Danaher Corporation by 2.5%, owning a total of 75,301 shares worth approximately $15.4 million at the end of the last quarter.
• Analyst sentiment is overall positive, with the average price target for Danaher set at $247.61, along with a strong "Moderate Buy" rating from several equity research firms.
• Danaher reported $1.80 earnings per share for the last quarter, surpassing estimates and showing a year-over-year revenue growth of 3.4% to $5.94 billion.

Thematics Asset Management grew its stake in Danaher Corporation (NYSE:DHR - Free Report) by 2.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 75,301 shares of the conglomerate's stock after purchasing an additional 1,805 shares during the period. Thematics Asset Management's holdings in Danaher were worth $15,437,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in DHR. GHP Investment Advisors Inc. grew its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter worth about $27,000. Sierra Ocean LLC grew its position in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after acquiring an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher in the 1st quarter valued at about $31,000. Finally, Dunhill Financial LLC increased its stake in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of DHR stock traded up $0.42 during trading hours on Thursday, reaching $205.42. The company had a trading volume of 2,519,753 shares, compared to its average volume of 4,185,368. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a market capitalization of $147.09 billion, a price-to-earnings ratio of 43.71, a PEG ratio of 2.88 and a beta of 0.73. The stock has a fifty day moving average of $201.23 and a 200-day moving average of $199.46.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the previous year, the firm earned $1.72 EPS. The company's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Evercore ISI lowered their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft decreased their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company cut their target price on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.